New Funding Opportunity! The Society of Interventional Oncology: Research Grant Opportunities
The SOCIETY OF INTERVENTIONAL ONCOLOGY is pleased to announce a call for research proposals on the combined topics of transarterial chemoembolization with lipiodol and immuno-oncology, which has been generously sponsored by Guerbet LLC. These grants are designed to fund a research evaluating and advancing the interactions between two premier interventional oncologic therapies.
Examples of the types of projects this initiative could support but is not limited to include:
- Pre-clinical studies that improve molecular biologic understanding of lipiodol’s interaction with the immune system within tumors or the liver.
- Innovative imaging and technical approaches in liver cancer using lipiodol including potentialization combined with immuno-oncologic therapies.
- Serologic and / or tissue and / or imaging biomarker studies linked to improving prediction of patient outcomes for lipiodol TACE when combined with immuno-oncologic approaches.
- Pre-clinical and clinical studies combining TACE with immunotherapies in primary or secondary liver cancer
Applicants should propose innovative research that advances the fields of interventional oncology, transcatheter tumor therapy, and immuno-oncology. Preliminary data are not required, but encouraged. High quality applications that address this solicitation will be given special consideration. This is a high priority mechanism and proposals that describe short time-lines for completion of the study and dissemination of results will be preferred.
Grant funding of up to $50,000 for one year exploratory pilot projects and up to $100,000 for larger one to two year projects with preliminary data will be provided.
Proposal are due 31 December 2019. Click here to learn more and submit a proposal.